Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus ...

Over a third of women giving birth got the new RSV vaccine in September, protecting newborns from severe illness. The new maternal Respiratory ...

The UKHSA is behind the new warning as a raft of illnesses, including flu, COVID, RSV, norovirus and hMPV, spread across the ...

Norovirus, also called the "winter vomiting bug", is a viral stomach bug that causes vomiting and diarrhoea. It can be very unpleasant, but usually goes away in about two days, the UKHSA said, adding: ...

Respiratory syncytial virus (RSV) leads to over 30 million severe respiratory infections, 3.5 million hospitalizations, and 100,000 deaths among children under five each year globally. Nearly half of ...

The covid wave this winter is less severe compared with previous years, with hospitalization rates down and wastewater levels ...

Respiratory Syncytial Virus, or RSV, has dominated headlines with an influx of cases across the country and here in Western ...

The child is currently being treated at a trust-run hospital and his condition is stable, a medical officer said ...

CASES of a virus that led to concerns in China of another Covid-like pandemic have risen in England, according to official figures. The UK has seen an assortment of winter illnesses surge this ...